Ten genes revealed to contribute to development of schizophrenia
Whole exome sequencing has been used by researchers to reveal 10 genes implicated in the development of schizophrenia.
List view / Grid view
Whole exome sequencing has been used by researchers to reveal 10 genes implicated in the development of schizophrenia.
The new research shows that astrocytes contribute to Huntington’s disease symptoms, but suppressing a mutation stops the disease from progressing.
A therapy has been developed which uses a synthetic RNA molecule developed to fight viruses to trigger an immune response against tumours in mice.
Researchers in the US have successfully produced a mouse model with a human MAPT gene to enable more accurate research into Alzheimer’s therapy.
A study has found a selective inhibitor for an enzyme that allows cancer cells to mutate and become resistant to treatments.
A drug discovery platform for mental health treatment could also help to identify mechanisms for the treatment of substance use disorders.
A simple and direct method of introducing lipids into protein has been developed using palladium as a catalyst.
Glycans, which are found in mucus, have the ability to regulate how microbes behave and could lead to new therapeutics.
New findings on dementia reveal that brain atrophy spreads via connected brain networks, rather than simply adjacent areas of the brain.
A team has used viral gene editing and CRISPR to form a system that marks tumours for destruction, potentially improving immunotherapies.
Cells containing Meflin play a role in restraining the progression of pancreatic cancer and could lead to new therapies against the disease.
Microglia brain immune cells are vital in conjunction with the APOE4 gene during the development of Alzheimer’s in mouse models, researchers have found.
Researchers have developed CRISPR-Cas13 enzyme-based technology that can be programmed to both detect and destroy RNA-based viruses in human cells.
A technique to 'trick' bacteria into revealing pores in their cell walls has been developed and targeting these could make antibiotics more effective.
A new platform has the potential to better understand what dictates the invasive behaviour of brain tumours.